XERS vs. FDVV
XERS (Xeris Biopharma Holdings, Inc.) is a stock, while FDVV (Fidelity High Dividend ETF) is Large Cap Blend Equities fund tracking the Fidelity Core Dividend Index. Over the past 5 years, XERS returned 12.09%/yr vs 13.69%/yr for FDVV. At a 0.27 correlation, their price movements are largely independent.
Performance
XERS vs. FDVV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XERS achieves a -12.10% return, which is significantly lower than FDVV's 8.39% return.
XERS
- 1D
- -0.72%
- 1M
- 11.47%
- YTD
- -12.10%
- 6M
- -4.30%
- 1Y
- 52.99%
- 3Y*
- 33.04%
- 5Y*
- 12.09%
- 10Y*
- —
FDVV
- 1D
- 0.08%
- 1M
- 0.43%
- YTD
- 8.39%
- 6M
- 8.10%
- 1Y
- 22.16%
- 3Y*
- 19.90%
- 5Y*
- 13.69%
- 10Y*
- —
XERS vs. FDVV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
XERS Xeris Biopharma Holdings, Inc. | -12.10% | 131.56% | 44.26% | 76.69% | -54.61% | -40.45% | -30.21% | -58.53% | 7.94% |
FDVV Fidelity High Dividend ETF | 8.39% | 17.08% | 21.81% | 18.00% | -4.21% | 29.24% | 2.80% | 24.07% | -5.58% |
Correlation
The correlation between XERS and FDVV is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Jun 21, 2018 | 0.27 |
The correlation between XERS and FDVV shifts across timeframes, from 0.22 (1 year) to 0.33 (3 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XERS vs. FDVV — Risk / Return Rank
XERS
FDVV
XERS vs. FDVV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xeris Biopharma Holdings, Inc. (XERS) and Fidelity High Dividend ETF (FDVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XERS | FDVV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -1.44 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.40 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 1.14 | 2.39 | -1.25 |
| Martin ratioReturn relative to average drawdown | 2.00 | 9.89 | -7.89 |
Loading charts...
Drawdowns
XERS vs. FDVV - Drawdown Comparison
The maximum XERS drawdown since its inception was -96.22%, which is greater than FDVV's maximum drawdown of -40.25%. Use the drawdown chart below to compare losses from any high point for XERS and FDVV.
Loading charts...
Drawdown Indicators
| XERS | FDVV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.22% | -40.25% | -55.97% |
Max Drawdown (1Y)Largest decline over 1 year | -46.57% | -9.30% | -37.27% |
Max Drawdown (3Y)Largest decline over 3 years | -49.83% | -15.90% | -33.93% |
Max Drawdown (5Y)Largest decline over 5 years | -78.59% | -20.18% | -58.41% |
Current DrawdownCurrent decline from peak | -74.66% | -1.31% | -73.35% |
Average DrawdownAverage peak-to-trough decline | -78.99% | -3.79% | -75.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.55% | 2.24% | +24.31% |
Volatility
XERS vs. FDVV - Volatility Comparison
Xeris Biopharma Holdings, Inc. (XERS) has a higher volatility of 9.77% compared to Fidelity High Dividend ETF (FDVV) at 3.09%. This indicates that XERS's price experiences larger fluctuations and is considered to be riskier than FDVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XERS | FDVV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.77% | 3.09% | +6.68% |
Volatility (6M)Calculated over the trailing 6-month period | 33.18% | 8.26% | +24.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.64% | 10.15% | +45.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.43% | 14.73% | +53.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.61% | 16.97% | +62.64% |
Dividends
XERS vs. FDVV - Dividend Comparison
XERS has not paid dividends to shareholders, while FDVV's dividend yield for the trailing twelve months is around 2.86%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FDVV Fidelity High Dividend ETF | 2.86% | 2.89% | 2.94% | 3.77% | 3.44% | 2.70% | 3.19% | 3.93% | 4.05% | 3.66% | 1.04% |
XERS Xeris Biopharma Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
XERS and FDVV have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XERS has higher volatility (9.77%) compared to FDVV (3.09%). In terms of maximum drawdown, XERS dropped -96.22% vs FDVV's -40.25%.
FDVV currently has the higher Sharpe Ratio (2.19 vs 0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XERS and FDVV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer